Alemtuzumab and Pentostatin In T-cell Neoplasms

NCT00453193 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

26

Enrollment

OTHER

Sponsor class

Stopped Slow accrual.

Conditions

Lymphoma
Leukemia

Interventions

DRUG: Pentostatin
DRUG: Alemtuzumab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]